Comparison between concurrent and sequential chemoradiation for non-small cell lung cancer in vitro

Seo Young Song, Amit K. Das, John D. Minna

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Current practice guidelines recommend the combination of chemotherapy and thoracic radiation for locally advanced non-small cell lung cancer (NSCLC). Previous meta-analyses have shown that concurrent chemoradiation (CCRT) may be superior to sequential chemoradiation (SCRT). However, few previous in vitro studies have analyzed these two treatment schedules. In the current study, four lung cancer cell lines harboring wild-type epidermal growth factor receptor, comprising two squamous and two non-squamous cell lines, were used. The IC10 concentrations of three platinum-based regimens were combined with radiation treatment. Cells were irradiated at 0, 2, 4, 6 and 8 Gy using a 137Cs irradiator concurrently or sequentially. Surviving fractions (SFs) were plotted as a function of the radiation dose. In A549 cells, only the docetaxel (Doc) and carboplatin (Carbo) combination showed a significant radiosensitizing effect with CCRT treatment. For the other three cell lines, no difference was identified in the SFs between CCRT and SCRT. An in vitro method of comparing CCRT with SCRT was established using lung cancer cell lines. Overall, no significant difference was detected in the radiosensitizing effect of the two treatment schedules, with the exception of the A549 cell lines treated with Doc/Carbo.

Original languageEnglish (US)
Pages (from-to)307-310
Number of pages4
JournalOncology Letters
Volume7
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

docetaxel
Non-Small Cell Lung Carcinoma
Radiation-Sensitizing Agents
Cell Line
Carboplatin
Radiation
Lung Neoplasms
Appointments and Schedules
Therapeutics
Combination Drug Therapy
Platinum
Practice Guidelines
Epidermal Growth Factor Receptor
Meta-Analysis
Thorax
In Vitro Techniques
A549 Cells

Keywords

  • Carcinoma
  • Cell line
  • Chemotherapy
  • Concurrent
  • Non-small cell lung cancer
  • Radiation
  • Sequential

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Comparison between concurrent and sequential chemoradiation for non-small cell lung cancer in vitro. / Song, Seo Young; Das, Amit K.; Minna, John D.

In: Oncology Letters, Vol. 7, No. 2, 02.2014, p. 307-310.

Research output: Contribution to journalArticle

@article{6817cbe72bbe4ce4a66cfb8d2ead0db1,
title = "Comparison between concurrent and sequential chemoradiation for non-small cell lung cancer in vitro",
abstract = "Current practice guidelines recommend the combination of chemotherapy and thoracic radiation for locally advanced non-small cell lung cancer (NSCLC). Previous meta-analyses have shown that concurrent chemoradiation (CCRT) may be superior to sequential chemoradiation (SCRT). However, few previous in vitro studies have analyzed these two treatment schedules. In the current study, four lung cancer cell lines harboring wild-type epidermal growth factor receptor, comprising two squamous and two non-squamous cell lines, were used. The IC10 concentrations of three platinum-based regimens were combined with radiation treatment. Cells were irradiated at 0, 2, 4, 6 and 8 Gy using a 137Cs irradiator concurrently or sequentially. Surviving fractions (SFs) were plotted as a function of the radiation dose. In A549 cells, only the docetaxel (Doc) and carboplatin (Carbo) combination showed a significant radiosensitizing effect with CCRT treatment. For the other three cell lines, no difference was identified in the SFs between CCRT and SCRT. An in vitro method of comparing CCRT with SCRT was established using lung cancer cell lines. Overall, no significant difference was detected in the radiosensitizing effect of the two treatment schedules, with the exception of the A549 cell lines treated with Doc/Carbo.",
keywords = "Carcinoma, Cell line, Chemotherapy, Concurrent, Non-small cell lung cancer, Radiation, Sequential",
author = "Song, {Seo Young} and Das, {Amit K.} and Minna, {John D.}",
year = "2014",
month = "2",
doi = "10.3892/ol.2013.1707",
language = "English (US)",
volume = "7",
pages = "307--310",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Comparison between concurrent and sequential chemoradiation for non-small cell lung cancer in vitro

AU - Song, Seo Young

AU - Das, Amit K.

AU - Minna, John D.

PY - 2014/2

Y1 - 2014/2

N2 - Current practice guidelines recommend the combination of chemotherapy and thoracic radiation for locally advanced non-small cell lung cancer (NSCLC). Previous meta-analyses have shown that concurrent chemoradiation (CCRT) may be superior to sequential chemoradiation (SCRT). However, few previous in vitro studies have analyzed these two treatment schedules. In the current study, four lung cancer cell lines harboring wild-type epidermal growth factor receptor, comprising two squamous and two non-squamous cell lines, were used. The IC10 concentrations of three platinum-based regimens were combined with radiation treatment. Cells were irradiated at 0, 2, 4, 6 and 8 Gy using a 137Cs irradiator concurrently or sequentially. Surviving fractions (SFs) were plotted as a function of the radiation dose. In A549 cells, only the docetaxel (Doc) and carboplatin (Carbo) combination showed a significant radiosensitizing effect with CCRT treatment. For the other three cell lines, no difference was identified in the SFs between CCRT and SCRT. An in vitro method of comparing CCRT with SCRT was established using lung cancer cell lines. Overall, no significant difference was detected in the radiosensitizing effect of the two treatment schedules, with the exception of the A549 cell lines treated with Doc/Carbo.

AB - Current practice guidelines recommend the combination of chemotherapy and thoracic radiation for locally advanced non-small cell lung cancer (NSCLC). Previous meta-analyses have shown that concurrent chemoradiation (CCRT) may be superior to sequential chemoradiation (SCRT). However, few previous in vitro studies have analyzed these two treatment schedules. In the current study, four lung cancer cell lines harboring wild-type epidermal growth factor receptor, comprising two squamous and two non-squamous cell lines, were used. The IC10 concentrations of three platinum-based regimens were combined with radiation treatment. Cells were irradiated at 0, 2, 4, 6 and 8 Gy using a 137Cs irradiator concurrently or sequentially. Surviving fractions (SFs) were plotted as a function of the radiation dose. In A549 cells, only the docetaxel (Doc) and carboplatin (Carbo) combination showed a significant radiosensitizing effect with CCRT treatment. For the other three cell lines, no difference was identified in the SFs between CCRT and SCRT. An in vitro method of comparing CCRT with SCRT was established using lung cancer cell lines. Overall, no significant difference was detected in the radiosensitizing effect of the two treatment schedules, with the exception of the A549 cell lines treated with Doc/Carbo.

KW - Carcinoma

KW - Cell line

KW - Chemotherapy

KW - Concurrent

KW - Non-small cell lung cancer

KW - Radiation

KW - Sequential

UR - http://www.scopus.com/inward/record.url?scp=84890399285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890399285&partnerID=8YFLogxK

U2 - 10.3892/ol.2013.1707

DO - 10.3892/ol.2013.1707

M3 - Article

VL - 7

SP - 307

EP - 310

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 2

ER -